Tamara Berthoud
Overview
Explore the profile of Tamara Berthoud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Imoukhuede E, Andrews L, Milligan P, Berthoud T, Bojang K, Nwakanma D, et al.
Am J Trop Med Hyg
. 2007 Mar;
76(3):486-93.
PMID: 17360872
The feasibility of using a sensitive polymerase chain reaction (PCR) to evaluate malaria vaccines in small group sizes was tested in 102 adult Gambian volunteers who received either the malaria...
12.
Bejon P, Keating S, Mwacharo J, Kai O, Dunachie S, Walther M, et al.
Infect Immun
. 2006 Sep;
74(11):6331-8.
PMID: 16966412
Two different cell populations respond to potent T-cell-inducing vaccinations. The induction and loss of effector cells can be seen using an ex vivo enzyme-linked immunospot (ELISPOT) assay, but the more...
13.
Walther M, Thompson F, Dunachie S, Keating S, Todryk S, Berthoud T, et al.
Infect Immun
. 2006 Apr;
74(5):2706-16.
PMID: 16622207
Heterologous prime-boost immunization with DNA and various recombinant poxviruses encoding malaria antigens is capable of inducing strong cell-mediated immune responses and partial protection in human sporozoite challenges. Here we report...
14.
Dunachie S, Walther M, Vuola J, Webster D, Keating S, Berthoud T, et al.
Vaccine
. 2006 Jan;
24(15):2850-9.
PMID: 16434127
Heterologous prime-boost immunisation with RTS,S/AS02A and the poxvirus MVA-CS was evaluated in 18 healthy malaria-naïve subjects in Oxford. Both priming with RTS,S and boosting MVA-CS, and the reverse, were found...
15.
Keating S, Bejon P, Berthoud T, Vuola J, Todryk S, Webster D, et al.
J Immunol
. 2005 Oct;
175(9):5675-80.
PMID: 16237057
Immunological memory is a required component of protective antimalarial responses raised by T cell-inducing vaccines. The magnitude of ex vivo IFN-gamma T cell responses is widely used to identify immunogenic...
16.
Gilbert S, Moorthy V, Andrews L, Pathan A, McConkey S, Vuola J, et al.
Vaccine
. 2005 Sep;
24(21):4554-61.
PMID: 16150517
T-cell-mediated responses against the liver-stage of Plasmodium falciparum are critical for protection in the human irradiated sporozoite model and several animal models. Heterologous prime-boost approaches, employing plasmid DNA and viral...
17.
Webster D, Dunachie S, Vuola J, Berthoud T, Keating S, Laidlaw S, et al.
Proc Natl Acad Sci U S A
. 2005 Mar;
102(13):4836-41.
PMID: 15781866
Malaria is a major global health problem for which an effective vaccine is required urgently. Prime-boost vaccination regimes involving plasmid DNA and recombinant modified vaccinia virus Ankara-encoding liver-stage malaria antigens...
18.
Vuola J, Keating S, Webster D, Berthoud T, Dunachie S, Gilbert S, et al.
J Immunol
. 2004 Dec;
174(1):449-55.
PMID: 15611270
Heterologous prime-boost vaccination has been shown to be an efficient way of inducing T cell responses in animals and in humans. We have used three vaccine vectors, naked DNA, modified...
19.
Walther M, Dunachie S, Keating S, Vuola J, Berthoud T, Schmidt A, et al.
Vaccine
. 2004 Dec;
23(7):857-64.
PMID: 15603885
ICC-1132, a recombinant virus-like particle comprising of a modified hepatitis B core protein with a B cell (NANP) and two T cell epitopes of Plasmodium falciparum circumsporozoite protein (CSP), was...